X
Private giants & exposure vehicles
Anduril, Shield AI, Skydio, Epirus, Neros — the names that define the sector without tickers, and the listed funds that hold them.
Who owns the choke
The US drone rearmament is being won by five companies that don't trade: Anduril, Shield AI, Skydio, Epirus and Neros. Anduril closed a $5B Series H at a $61B valuation in May 2026 after revenue doubled to $2.2B in 2025 — it has now raised over $11B, a capital moat no public small-cap drone name can match. Shield AI's Hivemind autonomy stack is licensed across the primes while its V-BAT flies in multi-domain service. Epirus owns the Army's IFPC-HPM counter-swarm lane with $43.5M of Gen II Leonidas orders and the first directed-energy defeat of a fiber-optic drone. Neros was the only vendor to deliver its full Phase I order in the Pentagon's $1.1B Drone Dominance program, and the Office of Strategic Capital is now discussing direct equity stakes — the customer is becoming a shareholder. Procurement law (NDAA China bans, the Blue UAS list) fences out DJI; capital intensity and clearances fence out new entrants.
Public access runs through four thin wrappers — three exchange-listed (VCX, DXYZ, XOVR) plus ARK's unlisted interval fund ARKVX — and the look-through is modest: Fundrise's VCX holds Anduril at 5.5% of net assets per its 3/31/26 SEC annual report; XOVR carries an Anduril SPV in its crossover sleeve; DXYZ holds Shield AI at 4.1% (as of 12/31/25); ARKVX carries Shield AI at ~1.2%. Scarcity, not NAV, sets the price — VCX touched ~$575 against a ~$19 NAV. That premium is the toll on a gate with no alternative.
What breaks it
Three vectors. An Anduril IPO is the clean break — it would democratize the core asset and deflate every wrapper premium; nothing is filed, but the Series H pulled the timeline debate forward. Commoditization from below is subtler: Gauntlet II's published unit-price caps — $4,500 for long-range strike, $3,500 for close-quarters urban assault — are explicitly designed to make FPV drones a commodity, which would reduce the Neros-layer moat to manufacturing throughput — replicable with enough capital. And the public pure-plays (AVAV, KTOS) attack from above, but they are losing the talent-and-capital flywheel: Anduril's single $5B Series H exceeds what almost any listed small-cap drone name is worth in its entirety.
The repricing event
It's dated. SpaceX prices June 11 and lists on Nasdaq June 12 at a fixed $135/share, implying roughly $1.77T — the largest IPO in history. Overnight, DXYZ and XOVR lose their biggest private asset to the public market (VCX is less exposed — SpaceX was its sixth-largest position at ~4%). Either the scarcity bid rotates into the next anchor private — Anduril, making the VCX and XOVR sleeves the only game in town — or premiums collapse toward look-through NAV and the wrappers reprice violently. Both paths force the market to mark this chokepoint within the quarter. Behind it, the Gauntlet II finals (≥$300M for 60,000 drones, late August) and AUSA (Oct 12–14) keep the program-award drumbeat live.
Who owns the choke
Anduril Industries
Pulsar is an AI-enabled, software-defined electromagnetic-attack family purpose-built for counter-UAS — backed by a $250M Pentagon c-UAS award, a SOCOM counter-drone IDIQ, and in March 2026 the first task order under the Army's new $20B counter-drone enterprise contract vehicle.
ARK Venture Fund
Interval fund running an 80%+ private book; its SEC N-CSRS (period ended Jan 2026) shows Shield AI Series F and Seed tranches at ~$6.8M combined fair value, roughly 1.2% of assets per the May 31, 2026 holdings list. Transacts at NAV — the cleanest pricing of any wrapper in this chokepoint. Unlisted closed-end interval fund — quoted as ARKVX but not exchange-traded; liquidity is quarterly NAV repurchases (~5%).
Destiny Tech100
Closed-end fund holding Shield AI at 4.1% of the portfolio (Series F1 preferred via Snowpoint Growth 2.5 SPV) per its Dec 31, 2025 schedule, with $127M deployed post-period into adjacent defense privates (Hermeus, Chaos Industries). Its drone exposure is real but small relative to its premium volatility.
Epirus
Leonidas, a solid-state high-power microwave system, is the leading one-to-many counter-swarm effector — IFPC-HPM prototypes delivered to the Army plus a $43.5M Gen II award — and attacks the chokepoint precisely where conventional RF jamming fails (RF-silent and swarming drones).
Shield AI (private)
Defense-autonomy unicorn whose V-BAT VTOL sits on the Blue UAS cleared list and whose Hivemind autonomy is built for NDAA-compliant platforms. Verified in ARK Venture Fund's published holdings (1.21% as of 5/31/2026) and reported as Destiny Tech100's second-largest position (~4%).
Fundrise Innovation Fund
NYSE-listed closed-end fund (listed March 2026) holding Anduril at 5.5% of net assets (4.5% co-invest vehicle + 1.1% Series Seed) and Anthropic at 16.5%, per the 3/31/2026 N-CSR/A — one of the few exchange-traded wrappers with direct Anduril exposure. Traded at extreme premiums to ~$19 NAV at listing; premium risk is the position.
Catalyst calendar
- 2026-06-12SpaceX (SPCX) Nasdaq debut — largest IPO in history (prices June 11)DXYZ and XOVR lose their biggest private asset to public markets overnight (SpaceX is a smaller ~4% slice of VCX, ~11% of ARKVX), forcing the scarcity bid to either rotate into Anduril sleeves or collapse premiums toward look-through NAV.
- 2026-08-24Pentagon Drone Dominance 'Gauntlet II' final competition and production down-select (late August)DIU's $300M+ Drone Dominance buy of up to 60,000 drones across ~10 vendors; Phase II unit caps are $4,500 (long-range strike) and $3,500 (close-quarters urban assault), $3,250 for munitions — the clearest demand signal for NDAA-compliant airframes and components.
- 2026-09-30FAA Part 108 BVLOS final rule (overdue vs. ~March 2026 executive-order target)The final BVLOS framework is the demand inflection for the US commercial drone base — most directly Skydio's domestic security and inspection franchise — and a re-rating trigger for everything fenced inside the Blue UAS moat.